The T2R to eNOS pathway, specifically polymorphisms regulating T2R38 signaling, has been identified as clinically important in terms of increased susceptibility to upper respiratory infections and impaired patient outcomes in chronic rhinosinusitis (CRS) [35,36,37,38,40,41,42,115,116,117]. The gene discussed is NOS3; the disease is respiratory tract infectious disorder.